neutropenia
Information
- Disease name
- neutropenia
- Disease ID
- DOID:1227
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04187898 | Active, not recruiting | Phase 1 | Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer | March 11, 2020 | July 31, 2024 |
| NCT04904614 | Active, not recruiting | Phase 4 | Letermovir Use in Heart Transplant Recipients | October 1, 2021 | December 30, 2025 |
| NCT04154488 | Active, not recruiting | Phase 1/Phase 2 | A Study of Mavorixafor in Participants With Congenital Neutropenia and Chronic Idiopathic Neutropenia Disorders | October 16, 2020 | July 2025 |
| NCT00001790 | Completed | Phase 1 | Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia | October 1998 | September 2000 |
| NCT00002643 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor | April 1995 | |
| NCT00002665 | Completed | Phase 2 | SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia | July 1995 | December 2003 |
| NCT00002693 | Completed | Phase 1 | Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia | October 1995 | April 2006 |
| NCT00002719 | Completed | Phase 3 | Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia | December 1995 | |
| NCT00002759 | Completed | Phase 1 | Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma | June 1996 | |
| NCT00002800 | Completed | Phase 2 | Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome | July 1996 | March 2003 |
| NCT00002866 | Completed | Phase 1 | Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer | August 12, 1996 | December 21, 2009 |
| NCT00003739 | Completed | Phase 3 | Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy | March 1999 | September 2006 |
| NCT00004192 | Completed | Phase 2 | Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma | May 1, 2000 | March 16, 2001 |
| NCT00004215 | Completed | Phase 2 | Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia | August 1999 | August 2000 |
| NCT02621905 | Completed | Phase 4 | Steady-State Comparative Bioavailability Study in Prophylaxis Patients of Lozanoc® 50 mg With Sporanox® 100 mg | November 2015 | December 2016 |
| NCT00001533 | Completed | Phase 1 | Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine | September 1996 | September 2000 |
| NCT00001646 | Completed | Phase 3 | Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis | August 1997 | August 2000 |
| NCT01187017 | Completed | Phase 1/Phase 2 | A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia | August 2010 | July 2012 |
| NCT01193283 | Completed | Phase 1/Phase 2 | Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia | August 2010 | September 2014 |
| NCT01229761 | Completed | Phase 2 | Study to Improve Survival Among HIV-Exposed Infants in Botswana | May 2011 | October 2018 |
| NCT01307579 | Completed | Phase 3 | Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia | April 4, 2011 | June 30, 2020 |
| NCT01371656 | Completed | Phase 3 | Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation | September 2011 | June 2017 |
| NCT01375608 | Completed | Phase 2 | Decitabine for High-Risk Sickle Cell Disease | June 2011 | February 2016 |
| NCT01431326 | Completed | Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care | November 2011 | November 2019 | |
| NCT01484015 | Completed | Phase 1 | Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia | February 2011 | October 2012 |
| NCT01611051 | Completed | Phase 3 | A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy | March 2012 | |
| NCT01629082 | Completed | Phase 1 | Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia | June 6, 2012 | June 27, 2018 |
| NCT01648322 | Completed | Phase 2 | Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy | June 2012 | December 2014 |
| NCT01669005 | Completed | The Utility of Multiplex PCR for Detection of DNA in Neutropenic Patients With Hematological Malignancies | November 2007 | December 2008 | |
| NCT01706562 | Completed | A Study of Empirical Antifungal Therapy With Itraconazole | May 2011 | September 2011 | |
| NCT01714570 | Completed | N/A | Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia | November 2012 | April 2014 |
| NCT01719432 | Completed | Effect of Body Mass on Filgrastim Pharmacokinetics | December 5, 2012 | December 2020 | |
| NCT01724866 | Completed | Phase 2 | Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer | March 25, 2013 | August 12, 2014 |
| NCT01916057 | Completed | N/A | Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis | November 19, 2013 | February 28, 2018 |
| NCT02119715 | Completed | Phase 2 | A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy | February 2011 | December 2012 |
| NCT02190721 | Completed | Phase 2 | A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement | May 12, 2015 | April 4, 2017 |
| NCT02231879 | Completed | Phase 2/Phase 3 | Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome | October 14, 2014 | February 24, 2021 |
| NCT02282215 | Completed | Phase 2 | Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia | December 2014 | September 22, 2017 |
| NCT02324231 | Completed | N/A | SPOG 2015 FN Definition. A Multi-center Non-inferiority Trial on Safety of a High Versus Low Temperature Limit Defining Fever in Pediatric Patients With Cancer at Risk for Fever in Chemotherapy-induced Neutropenia | April 2016 | September 15, 2018 |
| NCT02414581 | Completed | Phase 3 | Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7% | April 2015 | September 2016 |
| NCT02452034 | Completed | Phase 1 | Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097) | September 7, 2015 | September 3, 2018 |
| NCT02521441 | Completed | Phase 2 | A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy. | July 3, 2014 | December 22, 2015 |
| NCT02522234 | Completed | Phase 1/Phase 2 | A Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy | February 25, 2014 | August 19, 2015 |
| NCT02527746 | Completed | Phase 1 | Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy | December 2012 | December 2013 |
| NCT02544230 | Completed | Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia | January 2004 | December 2011 | |
| NCT02589301 | Completed | Phase 1 | Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim Formulations | November 2015 | November 2016 |
| NCT00001338 | Completed | Phase 3 | A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer | June 1993 | January 2001 |
| NCT02629289 | Completed | Phase 1 | A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy Participants | August 2015 | June 2016 |
| NCT02643420 | Completed | Phase 3 | SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE) | January 19, 2016 | October 31, 2018 |
| NCT02679443 | Completed | N/A | Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy | July 2015 | December 2016 |
| NCT02755857 | Completed | Phase 2 | Bioavailability Study of Lozanoc™ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis | July 2016 | January 2017 |
| NCT02774850 | Completed | Home Away From Home - Medical Outcomes | June 2015 | July 26, 2019 | |
| NCT02872103 | Completed | Phase 3 | Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy | August 2016 | December 20, 2017 |
| NCT02912117 | Completed | Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay | August 2016 | May 2018 | |
| NCT02953340 | Completed | Phase 3 | SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide | May 10, 2017 | May 6, 2019 |
| NCT03019939 | Completed | Phase 2 | Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia | March 28, 2017 | August 10, 2020 |
| NCT03252431 | Completed | Phase 3 | Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy | April 12, 2018 | March 5, 2020 |
| NCT03530072 | Completed | Use of NGS Cell-free Pathogen Test for Identification of Low Risk Fever & Neutropenia in Pediatric Patients | May 7, 2018 | October 31, 2019 | |
| NCT04009941 | Completed | Phase 4 | Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer | August 1, 2019 | January 31, 2020 |
| NCT04217811 | Completed | Late Neutropenia in VLBW Preterm Babies | January 1, 2020 | December 31, 2021 | |
| NCT04448301 | Completed | N/A | PC001- A Study to Evaluate the Usability of PointCheck | February 9, 2021 | June 30, 2023 |
| NCT04562922 | Completed | Phase 2 | LIFEMEL Efficacy in Preventing Haematopoietic Toxicity in Patients Treated With Chemotherapy | November 11, 2013 | April 4, 2016 |
| NCT04710212 | Completed | Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies | March 12, 2021 | February 28, 2022 | |
| NCT05221593 | Completed | Phase 3 | Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients | August 1, 2020 | June 1, 2022 |
| NCT05283616 | Completed | Phase 3 | Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer | May 15, 2017 | October 15, 2021 |
| NCT05585463 | Completed | Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021) | September 1, 2019 | October 31, 2021 | |
| NCT05793073 | Completed | AMS Intervention for Early Adaptation of Empirical Antibiotic Therapy in High-risk Neutropenic Patients | October 1, 2019 | May 31, 2022 | |
| NCT00005893 | Completed | N/A | Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders | June 2000 | |
| NCT00008840 | Completed | A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia | November 2005 | ||
| NCT00020371 | Completed | Phase 1 | BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy | September 2000 | |
| NCT00020527 | Completed | N/A | Caspofungin Acetate in Treating Children With Fever and Neutropenia | March 2001 | June 2003 |
| NCT00031980 | Completed | Phase 2 | Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer | March 2002 | May 2005 |
| NCT00035594 | Completed | Phase 3 | Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy | February 2002 | June 2004 |
| NCT00035620 | Completed | Phase 2 | Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy | April 2000 | April 2007 |
| NCT00044486 | Completed | Phase 3 | Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899) | July 2002 | April 2005 |
| NCT00048971 | Completed | Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy | April 2002 | November 2006 | |
| NCT00056381 | Completed | Phase 1/Phase 2 | Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17 | July 2003 | June 2004 |
| NCT00059423 | Completed | Natural History Study for BEN | June 3, 2003 | June 26, 2020 | |
| NCT00066599 | Completed | Phase 2 | Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy | June 2003 | June 2004 |
| NCT00068471 | Completed | Phase 1/Phase 2 | Anidulafungin in Treating Immunocompromised Children With Neutropenia | July 2003 | October 2007 |
| NCT00077311 | Completed | Phase 2 | Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | August 2004 | April 2009 |
| NCT00082537 | Completed | Phase 2 | MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044) | April 2004 | October 2006 |
| NCT00115414 | Completed | Phase 2 | Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC) | ||
| NCT00125723 | Completed | Phase 4 | FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy | May 2004 | December 2005 |
| NCT00129688 | Completed | N/A | Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children | April 2002 | June 2004 |
| NCT00138736 | Completed | Phase 2 | Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia | April 2004 | October 2006 |
| NCT00174473 | Completed | Phase 1/Phase 2 | A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children | June 2003 | August 2005 |
| NCT00257790 | Completed | Phase 4 | The Tobramycin Study | September 2001 | March 2005 |
| NCT00260689 | Completed | Phase 2 | Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia | November 28, 2005 | May 4, 2016 |
| NCT00277160 | Completed | Phase 4 | A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer | June 2002 | January 2005 |
| NCT00335478 | Completed | Phase 2 | Daptomycin in Treating Neutropenia and Fever in Patients With Cancer | December 2006 | October 2008 |
| NCT00352300 | Completed | Phase 1 | Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer | June 2006 | |
| NCT00364468 | Completed | Phase 2 | Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients | March 2006 | March 2008 |
| NCT00497809 | Completed | Phase 2 | Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia | August 2007 | July 2009 |
| NCT00608738 | Completed | N/A | Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment | July 2001 | January 2005 |
| NCT00627393 | Completed | Phase 3 | Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study) | April 2008 | May 2013 |
| NCT00686543 | Completed | Phase 4 | Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115) | December 2007 | April 2009 |
| NCT00730314 | Completed | Phase 1/Phase 2 | Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells | August 2008 | August 2015 |
| NCT00770172 | Completed | Phase 3 | G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy | October 2007 | |
| NCT00771433 | Completed | Phase 2 | G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer | October 2007 | |
| NCT00771810 | Completed | Phase 2 | Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer | October 2008 | December 2011 |
| NCT00784368 | Completed | Phase 3 | A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection | January 2008 | May 2009 |
| NCT00816088 | Completed | Diagnostic and Management Strategies for Invasive Aspergillosis | December 2008 | December 2011 | |
| NCT00911170 | Completed | Phase 3 | PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study | November 3, 2009 | January 2, 2015 |
| NCT00913042 | Completed | Assessment of New Blood Culture Methods on the Microbiological Documentation of Febrile Neutropenia | February 2008 | April 2009 | |
| NCT01021683 | Completed | The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants | July 2009 | July 2010 | |
| NCT01058993 | Completed | Phase 1 | AMD 3100 for Treatment of Myelokathexis | October 2010 | April 2011 |
| NCT01060462 | Completed | Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients | August 2008 | February 2009 | |
| NCT01086878 | Completed | Phase 4 | Safety of Cotrimoxazole in HIV- and HAART-exposed Infants | February 2009 | October 2010 |
| NCT01114165 | Completed | Phase 4 | Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients | May 2010 | September 2012 |
| NCT01164215 | Completed | Phase 1 | Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy | February 2010 | September 2013 |
| NCT06056297 | Not yet recruiting | Phase 3 | A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections | March 2024 | July 2025 |
| NCT05852249 | Not yet recruiting | Investigation of the Usability of Neutrocheck Amongst Healthy Volunteers and Healthcare Professionals. | August 2023 | October 2023 | |
| NCT05672420 | Not yet recruiting | Phase 1/Phase 2 | Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies | January 1, 2023 | January 31, 2025 |
| NCT06360952 | Not yet recruiting | A Comparator Study of a Tasso Device Blood Sample to Traditional Venous Blood Sample for CBC | May 31, 2024 | August 31, 2024 | |
| NCT06245746 | Not yet recruiting | Phase 1 | UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia | March 2024 | December 2025 |
| NCT00967785 | Recruiting | Phase 1/Phase 2 | A Phase I Study of Mozobil in the Treatment of Patients With WHIMS | January 6, 2010 | June 30, 2024 |
| NCT05626530 | Recruiting | Phase 4 | Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients | February 2, 2023 | December 15, 2025 |
| NCT06145321 | Recruiting | Phase 4 | Continuous Versus Bolus Administration of G-CSF in Children With Cancer | November 23, 2023 | November 15, 2024 |
| NCT05537896 | Recruiting | Phase 2 | Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia | February 19, 2024 | February 2028 |
| NCT01821456 | Recruiting | Cologne Cohort of Neutropenic Patients (CoCoNut) | January 1995 | December 2050 | |
| NCT06422533 | Recruiting | N/A | Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients | November 7, 2023 | August 30, 2025 |
| NCT06107322 | Recruiting | Hematological Effects of Atypical Antipsychotics (AAPs) in a Geriatric Population: What is the Role of 5-HT2 Receptors | March 1, 2023 | March 23, 2024 | |
| NCT00107081 | Terminated | Phase 3 | Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting | January 2004 | December 2007 |
| NCT00937053 | Terminated | Phase 2 | Maintaining a Higher Level of Haemoglobin: Effect on the White Cells After Bone Marrow Transplantation in Children. | June 2009 | June 2015 |
| NCT00947648 | Terminated | Phase 2 | Outpatient Neutropenic Diet Study | July 2009 | March 2013 |
| NCT00062231 | Terminated | N/A | Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer | April 2002 | |
| NCT00005787 | Terminated | Phase 1 | Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma | September 1999 | January 2002 |
| NCT00194857 | Terminated | Phase 4 | Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin | February 2002 | December 2005 |
| NCT00529282 | Terminated | Phase 3 | A Study of Ceftobiprole in Patients With Fever and Neutropenia. | October 2007 | January 2008 |
| NCT02685111 | Terminated | Phase 2 | Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC) | February 2016 | December 2017 |
| NCT00806351 | Terminated | Phase 3 | An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System | August 2009 | October 2011 |
| NCT03498248 | Unknown status | N/A | Efficacy of Granulocyte-Colony Stimulating Factor (G-CSF) | February 19, 2018 | August 31, 2019 |
| NCT01918241 | Unknown status | Phase 2 | Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia | July 2013 | |
| NCT01714557 | Unknown status | N/A | Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation | September 2012 | November 2014 |
| NCT02967341 | Unknown status | Phase 4 | Blood Draw Validation for Ciprofloxacin Pharmacokinetic Research in Pediatric Cancer Patients | March 2016 | March 2017 |
| NCT01135589 | Unknown status | Phase 4 | Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation | April 2010 | May 2012 |
| NCT02238873 | Unknown status | Phase 3 | Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive Lymphoma | October 2014 | |
| NCT02135887 | Unknown status | A Trial of MB-6 for Reduction of Neutropenia Induced by Chemotherapy in Patients With Stage III Colorectal Cancer. | November 4, 2013 | December 31, 2022 | |
| NCT03798665 | Unknown status | A Real World Study Evaluating the Clinical Application of PEG-rhG-CSF During Chemotherapy in Patients With Solid Tumors | July 6, 2018 | July 6, 2019 | |
| NCT01417169 | Unknown status | Phase 2 | Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation | August 2011 | December 2014 |
| NCT02806557 | Unknown status | Profiling Neutrophil Counts in Patients on Chemotherapy | September 2016 | March 2018 | |
| NCT00247039 | Unknown status | Phase 1/Phase 2 | Garlic in Patients With Febrile Neutropenia | June 2006 | August 2013 |
| NCT00002658 | Unknown status | Phase 3 | Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia | January 1994 | |
| NCT02544685 | Unknown status | Phase 2 | Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer Patients | July 2010 | October 2019 |
| NCT01560195 | Unknown status | Phase 3 | A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy | April 2012 | |
| NCT01571518 | Unknown status | Phase 4 | Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy | April 2012 | October 2013 |
| NCT00004342 | Unknown status | International Registry for Severe Chronic Neutropenia | June 1994 | ||
| NCT00445497 | Unknown status | Phase 3 | Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia | July 2007 | |
| NCT01637493 | Unknown status | Phase 1 | Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients | February 2012 | June 2013 |
| NCT04873765 | Unknown status | Phase 1 | Biosimilarity Study of Subcutaneous Pegfilgrastim in Healthy Volunteers | March 18, 2022 | September 18, 2022 |
| NCT00555516 | Unknown status | Phase 1/Phase 2 | A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy | November 2007 | June 2009 |
| NCT00030758 | Unknown status | Phase 4 | Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer | October 2001 | |
| NCT00673348 | Unknown status | Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations | May 2008 | April 2010 | |
| NCT00020865 | Unknown status | Phase 3 | Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia | September 2001 | |
| NCT03768869 | Withdrawn | Phase 3 | Fever and Neutropenia in Pediatric Oncology Patients | February 2006 | April 3, 2009 |
| NCT00003407 | Withdrawn | Phase 2 | Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML | February 13, 2001 | April 7, 2004 |
| NCT00886496 | Withdrawn | Phase 1 | Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia | November 2006 | April 2011 |
| NCT00296049 | Withdrawn | N/A | Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy | July 2005 | March 2006 |
| NCT01660347 | Withdrawn | N/A | Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant | August 2012 | December 2014 |
| NCT00520325 | Withdrawn | Phase 1 | A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia | June 2007 | August 2009 |
- Disase is a (Disease Ontology)
- DOID:12987
- Cross Reference ID (Disease Ontology)
- ICD10CM:D70
- Cross Reference ID (Disease Ontology)
- ICD9CM:288.0
- Cross Reference ID (Disease Ontology)
- MESH:D009503
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:191336001
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0027947
- HPO alt_id (Human Phenotype Ontology)
- HP:0005515
- HPO alt_id (Human Phenotype Ontology)
- HP:0005533
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0001875
- MeSH unique ID (MeSH (Medical Subject Headings))
- D009503